These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20426913)

  • 41. Quantitative scintigraphy using radiophosphate and radiogallium in patients with rheumatoid arthritis.
    Tannenbaum H; Rosenthall L; Arzoumanian A
    Clin Exp Rheumatol; 1987; 5(1):17-21. PubMed ID: 3474091
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Functional disability in relation to radiological damage and disease activity in patients with rheumatoid arthritis in remission.
    Molenaar ET; Voskuyl AE; Dijkmans BA
    J Rheumatol; 2002 Feb; 29(2):267-70. PubMed ID: 11842821
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Remission in patients with active rheumatoid arthritis by tocilizumab treatment in routine clinical practice: results from 3 years of prospectively registered data.
    Nakashima Y; Kondo M; Fukuda T; Harada H; Horiuchi T; Ishinishi T; Jojima H; Kuroda K; Miyahara H; Maekawa M; Nishizaka H; Nagamine R; Nakashima H; Otsuka T; Shono E; Suematsu E; Shimauchi T; Tsuru T; Wada K; Yoshizawa S; Yoshizawa S; Iwamoto Y
    Mod Rheumatol; 2014 Mar; 24(2):258-64. PubMed ID: 24593201
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The prevalence of clinical remission in RA patients treated with anti-TNF: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.
    de Punder YM; Fransen J; Kievit W; Houtman PM; Visser H; van de Laar MA; van Riel PL
    Rheumatology (Oxford); 2012 Sep; 51(9):1610-7. PubMed ID: 22539487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Remission in early rheumatoid arthritis -- a comparison of new ACR/EULAR remission criteria to established criteria.
    Kuriya B; Sun Y; Boire G; Haraoui B; Hitchon C; Pope JE; Thorne JC; Keystone EC; Bykerk VP;
    J Rheumatol; 2012 Jun; 39(6):1155-8. PubMed ID: 22505708
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Usefulness of hybrid SPECT/CT in 99mTc-HMPAO-labeled leukocyte scintigraphy for bone and joint infections.
    Filippi L; Schillaci O
    J Nucl Med; 2006 Dec; 47(12):1908-13. PubMed ID: 17138732
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Are there differences between young- and older-onset early inflammatory arthritis and do these impact outcomes? An analysis from the CATCH cohort.
    Arnold MB; Bykerk VP; Boire G; Haraoui BP; Hitchon C; Thorne C; Keystone EC; Pope JE;
    Rheumatology (Oxford); 2014 Jun; 53(6):1075-86. PubMed ID: 24501240
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Remission in early rheumatoid arthritis defined by 28 joint counts: limited consequences of residual disease activity in the forefeet on outcome.
    van Tuyl LH; Britsemmer K; Wells GA; Smolen JS; Zhang B; Funovits J; van Schaardenburg D; Felson D; Boers M
    Ann Rheum Dis; 2012 Jan; 71(1):33-7. PubMed ID: 21953347
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comprehensive appraisal of magnetic resonance imaging findings in sustained rheumatoid arthritis remission: a substudy.
    Ranganath VK; Motamedi K; Haavardsholm EA; Maranian P; Elashoff D; McQueen F; Duffy EL; Bathon JM; Curtis JR; Chen W; Moreland L; Louie J; Amjadi S; O'Dell J; Cofield SS; St Clair EW; Bridges SL; Paulus HE
    Arthritis Care Res (Hoboken); 2015 Jul; 67(7):929-39. PubMed ID: 25581612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort.
    Combe B; Logeart I; Belkacemi MC; Dadoun S; Schaeverbeke T; Daurès JP; Dougados M
    Ann Rheum Dis; 2015 Apr; 74(4):724-9. PubMed ID: 24399234
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Technetium-99m nanocolloid scintigraphy in rheumatic inflammation in children.
    Mäkelä AL; Soini I; Mäkelä P
    Acta Univ Carol Med (Praha); 1991; 37(1-2):61-7. PubMed ID: 1845410
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic markers of clinical remission in early rheumatoid arthritis after two years of DMARDs in a clinical setting.
    Vázquez I; Graell E; Gratacós J; Cañete JD; Viñas O; Ercilla MG; Gómez A; Hernández MV; Rodríguez-Cros JR; Larrosa M; Sanmartí R
    Clin Exp Rheumatol; 2007; 25(2):231-8. PubMed ID: 17543147
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discontinuation of infliximab in rheumatoid arthritis patients in clinical remission.
    Nawata M; Saito K; Nakayamada S; Tanaka Y
    Mod Rheumatol; 2008; 18(5):460-4. PubMed ID: 18535759
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Whole-body FDG-PET/CT on rheumatoid arthritis of large joints.
    Kubota K; Ito K; Morooka M; Mitsumoto T; Kurihara K; Yamashita H; Takahashi Y; Mimori A
    Ann Nucl Med; 2009 Nov; 23(9):783-91. PubMed ID: 19834653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sustained remission and reduced radiographic progression with combination disease modifying antirheumatic drugs in early rheumatoid arthritis.
    Mäkinen H; Kautiainen H; Hannonen P; Möttönen T; Leirisalo-Repo M; Laasonen L; Korpela M; Blåfield H; Hakola M; Sokka T
    J Rheumatol; 2007 Feb; 34(2):316-21. PubMed ID: 17183623
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactants.
    Smolen JS; Aletaha D
    Arthritis Rheum; 2011 Jan; 63(1):43-52. PubMed ID: 21204103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation between morphological and functional liver volume in each sector using integrated SPECT/CT imaging by computed tomography and technetium-99m galactosyl serum albumin scintigraphy in patients with various diseases who had undergone hepatectomy.
    Nanashima A; Abo T; Tobinaga S; Murakami G; Kido Y; Fukuda T; Tsuchiya T; Matsumoto H; Nagayasu T; Kudo T
    Nucl Med Commun; 2013 Jul; 34(7):652-9. PubMed ID: 23652207
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sustained beneficial effects of a protocolized treat-to-target strategy in very early rheumatoid arthritis: three-year results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort.
    Vermeer M; Kuper HH; Moens HJ; Drossaers-Bakker KW; van der Bijl AE; van Riel PL; van de Laar MA
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1219-26. PubMed ID: 23436821
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Magnetic resonance imaging and bone scintigraphy in the differential diagnosis of unclassified arthritis.
    Duer A; Østergaard M; Hørslev-Petersen K; Vallø J
    Ann Rheum Dis; 2008 Jan; 67(1):48-51. PubMed ID: 17289759
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Technetium-99m labelled polyclonal human IgG scintigraphy before and 26 weeks after initiation of parenteral gold treatment in patients with rheumatoid arthritis.
    de Bois MH; Westedt ML; Arndt JW; Wiarda KS; van der Velde EA; Pauwels EK; Breedveld FC
    J Rheumatol; 1995 Aug; 22(8):1461-5. PubMed ID: 7473466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.